1
/
of
0
FDA Drug Approval, N201532, HALAVEN
FDA Drug Approval, N201532, HALAVEN
Regular price
$89.00 USD
Regular price
Sale price
$89.00 USD
Unit price
/
per
NDA: 201532
Company: EISAI INC
Drug Name: HALAVEN
Active Ingredients: ERIBULIN MESYLATE
Strength: SOLUTION;INTRAVENOUS
Dosage Form/Route: Prescription
Action Date: ORIG-1
Marketing Status: AP
Submission Classification: PRIORITY
Company: EISAI INC
Drug Name: HALAVEN
Active Ingredients: ERIBULIN MESYLATE
Strength: SOLUTION;INTRAVENOUS
Dosage Form/Route: Prescription
Action Date: ORIG-1
Marketing Status: AP
Submission Classification: PRIORITY
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details